GP Petroleums Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 18, 2025, 5:12 pm

Competitors of GP Petroleums Ltd

All Competitor Stocks of GP Petroleums Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:10 am

Below is a detailed analysis of the quarterly data for GP Petroleums Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 158.19 Cr.. The value appears to be declining and may need further review. It has decreased from 182.36 Cr. (Mar 2025) to 158.19 Cr., marking a decrease of 24.17 Cr..
• For Expenses, as of Jun 2025, the value is 148.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 169.82 Cr. (Mar 2025) to 148.71 Cr., marking a decrease of 21.11 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.48 Cr.. The value appears to be declining and may need further review. It has decreased from 12.54 Cr. (Mar 2025) to 9.48 Cr., marking a decrease of 3.06 Cr..
• For OPM %, as of Jun 2025, the value is 5.99%. The value appears to be declining and may need further review. It has decreased from 6.88% (Mar 2025) to 5.99%, marking a decrease of 0.89%.
• For Other Income, as of Jun 2025, the value is 0.59 Cr.. The value appears strong and on an upward trend. It has increased from 0.38 Cr. (Mar 2025) to 0.59 Cr., marking an increase of 0.21 Cr..
• For Interest, as of Jun 2025, the value is 0.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.36 Cr., marking an increase of 0.20 Cr..
• For Depreciation, as of Jun 2025, the value is 1.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.18 Cr. (Mar 2025) to 1.15 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 8.56 Cr.. The value appears to be declining and may need further review. It has decreased from 11.58 Cr. (Mar 2025) to 8.56 Cr., marking a decrease of 3.02 Cr..
• For Tax %, as of Jun 2025, the value is 24.88%. The value appears to be improving (decreasing) as expected. It has decreased from 25.65% (Mar 2025) to 24.88%, marking a decrease of 0.77%.
• For Net Profit, as of Jun 2025, the value is 6.44 Cr.. The value appears to be declining and may need further review. It has decreased from 8.62 Cr. (Mar 2025) to 6.44 Cr., marking a decrease of 2.18 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.26. The value appears to be declining and may need further review. It has decreased from 1.69 (Mar 2025) to 1.26, marking a decrease of 0.43.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:16 am

Growth

Last Updated: September 5, 2025, 5:15 am

Balance Sheet

Last Updated: September 10, 2025, 1:47 pm

Below is a detailed analysis of the balance sheet data for GP Petroleums Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
• For Reserves, as of Mar 2025, the value is 303.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2024) to 303.00 Cr., marking an increase of 25.00 Cr..
• For Borrowings, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 18.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 15.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 43.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 405.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 364.00 Cr. (Mar 2024) to 405.00 Cr., marking an increase of 41.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2024) to 69.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 291.00 Cr. (Mar 2024) to 336.00 Cr., marking an increase of 45.00 Cr..
• For Total Assets, as of Mar 2025, the value is 405.00 Cr.. The value appears strong and on an upward trend. It has increased from 364.00 Cr. (Mar 2024) to 405.00 Cr., marking an increase of 41.00 Cr..

Notably, the Reserves (303.00 Cr.) exceed the Borrowings (33.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for GP Petroleums Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.16. This value is within the healthy range. It has decreased from 5.44 (Mar 24) to 5.16, marking a decrease of 0.28.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.16. This value is within the healthy range. It has decreased from 5.44 (Mar 24) to 5.16, marking a decrease of 0.28.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.09. This value is within the healthy range. It has decreased from 6.33 (Mar 24) to 6.09, marking a decrease of 0.24.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.52. It has increased from 59.49 (Mar 24) to 64.52, marking an increase of 5.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.52. It has increased from 59.49 (Mar 24) to 64.52, marking an increase of 5.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 119.50. It has decreased from 128.50 (Mar 24) to 119.50, marking a decrease of 9.00.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.12. This value is within the healthy range. It has decreased from 8.26 (Mar 24) to 8.12, marking a decrease of 0.14.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.19. This value is within the healthy range. It has decreased from 7.36 (Mar 24) to 7.19, marking a decrease of 0.17.
• For PBT / Share (Rs.), as of Mar 25, the value is 6.96. This value is within the healthy range. It has decreased from 7.29 (Mar 24) to 6.96, marking a decrease of 0.33.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.16. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 5.16, marking a decrease of 0.27.
• For PBDIT Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 10. It has increased from 6.42 (Mar 24) to 6.79, marking an increase of 0.37.
• For PBIT Margin (%), as of Mar 25, the value is 6.01. This value is below the healthy minimum of 10. It has increased from 5.73 (Mar 24) to 6.01, marking an increase of 0.28.
• For PBT Margin (%), as of Mar 25, the value is 5.82. This value is below the healthy minimum of 10. It has increased from 5.67 (Mar 24) to 5.82, marking an increase of 0.15.
• For Net Profit Margin (%), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 4.22 (Mar 24) to 4.32, marking an increase of 0.10.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 15. It has decreased from 9.13 (Mar 24) to 8.00, marking a decrease of 1.13.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.84. This value is within the healthy range. It has decreased from 11.87 (Mar 24) to 10.84, marking a decrease of 1.03.
• For Return On Assets (%), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.62 (Mar 24) to 6.49, marking a decrease of 1.13.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.07, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.58. It has decreased from 1.85 (Mar 24) to 1.58, marking a decrease of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 4.95. This value exceeds the healthy maximum of 3. It has decreased from 6.06 (Mar 24) to 4.95, marking a decrease of 1.11.
• For Quick Ratio (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 2. It has decreased from 4.35 (Mar 24) to 3.73, marking a decrease of 0.62.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.50. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 7.50, marking an increase of 2.40.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 34.19. This value is within the healthy range. It has decreased from 107.27 (Mar 24) to 34.19, marking a decrease of 73.08.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.73. This value is within the healthy range. It has decreased from 71.62 (Mar 24) to 22.73, marking a decrease of 48.89.
• For Enterprise Value (Cr.), as of Mar 25, the value is 209.98. It has decreased from 313.45 (Mar 24) to 209.98, marking a decrease of 103.47.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.34, marking a decrease of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 5.07. This value is within the healthy range. It has decreased from 7.45 (Mar 24) to 5.07, marking a decrease of 2.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.31, marking a decrease of 0.16.
• For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.57, marking a decrease of 0.45.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.31, marking a decrease of 0.16.
• For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.13, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness